Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Herbal treatments can help manage PCOS symptoms.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.